Clinical Trials & Translational Medicine

Conferences & Courses
Leaders in BioBanking Congress Leaders in BioBanking Congress
July 14-16, 2015 | Toronto, ON Canada
Today, biospecimen collections are used by multiple research groups for various research aims, from basic research through clinical trials.

GPCR-Based Drug Discovery Part 1 GPCR-Based Drug Discovery Part 1
September 22-23, 2015 | Boston, MA
Despite their fruitful history in the drug development industry, discovering or designing new therapeutic agents that modulate a GPCR in a specific way is still a challenge, and in fact is undergoing a renewal because of explosion of new knowledge about t

Targeting the Unfolded Protein Response Targeting the Unfolded Protein Response
September 23-24, 2015 | Boston, MA
Protein-Protein Interactions as Drug Targets Conference, part of Discovery on Target 2014 in Boston, explores current PPI targets and new approaches for identifying PPI inhibitors for medical therapies.

Life Science Media Library
Clinical Trial Monitoring and Compliance Clinical Trial Monitoring and Compliance
February 4, 2013 |
In this DVD, we will discuss the ever-changing role of the CRA and explore ways in which this relationship can be leveraged to maximize productivity with study sites. Key topics to be addressed: How to build and maintain the relationship between sponsor and site Ways to partner with your sites during different phases of clinical trials How to have an enrollment discussion with your site; define mutual goals and expectations How to ensure ROI on territory development activities
Impact of Affordable Care Act and the Sunshine Act on Industry Impact of Affordable Care Act and the Sunshine Act on Industry
February 4, 2013 |
In this DVD, we will discuss the new "sunshine provisions" in the Patient Protection and Affordable Health Care Act ("PPACA") and its implications and effects on clinical trial operations. Key topics to be addressed: Insurance coverage and strategies to improve clinical trial enrollment What is the Sunshine Act and what are the company’s legal requirements? Opportunities in the Biosimilars FDA rules and changes in operations What are first steps and strategies to become compliant with state and federal laws? How can companies maintain flexibility in dealing with evolving legislation? What business processes and systems are involved? Implementation struggles: Centralization of all payments; FMV process and standardization and the effect Change Management with Study teams: The balance of compliance and challenges of patient recruitment, site shortage
Clinical Assay Development Clinical Assay Development
September 19, 2012 |
Presentations selected from the Clinical Assay Development workshop at the Fourth Annual ADAPT Congress 2012 discuss how discovery and research assays are increasingly being converted into clinically useful assays that are used in clinical trials to improve patient outcome and to support drug development. Regulatory issues and the dedication of resources to develop assays are addressed, as well as strategies to overcome the challenges of using commercial assays on clinical samples; analytical validation studies to determine clinical utility; and the benefits of working with a diagnostics organization with both experienced IVD manufacturing and an extensive CLIA laboratory infrastructure.

Publications, Reports, & Whitepapers
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.